Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Boston Convention and Exhibition Center

Jun 23, 2013 8:30 AM - Jun 27, 2013 12:45 PM

415 Summer Street, , Boston, MA 02210 , USA

DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science

Is This Trial Worth It? A Panel Discussion for Sites and Project Managers

Session Chair(s)

Rodney  Butt, MBA, MSc

Rodney Butt, MBA, MSc

President - Strategic Solutions

BV Medical Research, Canada

Financial pressures are increasing at both the sponsor level and the site level. The implementation of sophisticated models and the introduction of Fair Market Value make study evaluation and discussions more challenging for sites and sponsors.

Learning Objective : Discuss the financial state at investigator sites from the sponsor/CRO level; Recognize how investigator sites can better understand true costs for a particular trial; Describe costing models that are used by project managers and study staff.

Speaker(s)

Adam  Chasse, MHA

Investigator Site Perspective

Adam Chasse, MHA

Guardian Research Network, United States

Director of Clinical Trial Operations

Andrew  Townshend

CRO Project Manager Perspective

Andrew Townshend

Syneos Health, United States

Senior Vice President, Alliance Development

Jess  Dolfi, MS

Grant Planning: It's Harder than You Think

Jess Dolfi, MS

Medidata Solutions, United States

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.